CrossRef Genetic risk of steatotic liver disease: Pathogenesis, prognosis, and implications for treatment Julia Kozlitina, Stefano Romeo, Helen H
Allina Health in Minnesota cut GLP-1 coverage from its own employee health plan
If you are in eating disorder recovery, GLP-1s are not a safe choice
Initial blood work: Included with membership If your provider requests lab testing, you can visit any Quest location for free
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
When you choose VIP Health Wellness & Recovery, you gain access to collaborative wellness services and medical care that is patient-centered
